002010:SZSETransfar Zhilian Co., Ltd. Analysis
Data as of 2026-03-15 - not real-time
CN¥6.31
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading just above a key support level with the 20‑day SMA marginally above the 50‑day SMA, indicating a short‑term bullish bias, while the MACD histogram remains negative and the RSI sits in the neutral zone. Volume has been stable and beta is low, suggesting limited price swings relative to the market, yet recent volatility has been elevated and sentiment leans toward greed.
Fundamental outlook: Revenue is growing modestly and margins are thin, resulting in a high trailing P/E but a price‑to‑book below one, which points to a mixed valuation picture. The company delivers a respectable dividend yield with a payout ratio near fifty percent, supported by positive operating cash flow, but carries a high debt‑to‑equity ratio that raises leverage concerns. Overall, the stock presents a blend of value and growth characteristics with moderate upside potential.
Fundamental outlook: Revenue is growing modestly and margins are thin, resulting in a high trailing P/E but a price‑to‑book below one, which points to a mixed valuation picture. The company delivers a respectable dividend yield with a payout ratio near fifty percent, supported by positive operating cash flow, but carries a high debt‑to‑equity ratio that raises leverage concerns. Overall, the stock presents a blend of value and growth characteristics with moderate upside potential.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price close to support level
- bearish MACD momentum
- elevated short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- bullish SMA alignment
- steady dividend yield
- potential upside above resistance
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- low beta indicating defensive profile
- high leverage requiring monitoring
- stable cash flow supporting dividend
Key Metrics & Analysis
Financial Health
Revenue Growth2.60%
Profit Margin2.11%
P/E Ratio33.2
ROE3.40%
ROA1.26%
Debt/Equity70.33
P/B Ratio0.8
Op. Cash FlowCN¥1.5B
Free Cash FlowCN¥628.1M
Technical Analysis
TrendBullish
RSI42.1
SupportCN¥6.22
ResistanceCN¥6.89
MA 20CN¥6.53
MA 50CN¥6.46
MA 200CN¥6.08
MACDBearish
VolumeStable
Fear & Greed Index72.88
Valuation
Target PriceCN¥6.95
Upside/Downside10.14%
GradeFair
TypeBlend
Dividend Yield2.38%
Risk Assessment
Beta0.22
Volatility31.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.